Sfoglia per Autore
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling.
2008 Giulia Cantini; Adriana Lombardi; Elisabetta Piscitelli; Giada Poli; Elisabetta Ceni; Sara Marchiani; Tonino Ercolino; Andrea Galli; Mario Serio; Massimo Mannelli; Michaela Luconi
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells
2008 A. Lombardi; G. Cantini; E. Piscitelli; S. Gelmini; M. Francalanci; T. Mello; E. Ceni; G. Varano; G. Forti; M. Rotondi; A. Galli; M. Serio; M. Luconi
Alcohol induced hepatic fibrosis: role of acetaldehyde.
2008 Tommaso Mello; Elisabetta Ceni; Calogero Surrenti; Andrea Galli
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN
2009 M. Tarocchi;E. Ceni;T. Mello;S. Polvani;F. Buccoliero;L. Cioni;B. Ottanelli;V. Foresta;S. Milani;A. Galli
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism.
2010 Cantini G; Lombardi A; Borgogni E; Francalanci M; Ceni E; Degl'Innocenti S; Gelmini S; Poli G; Galli A; Serio M; Forti G; Luconi M.
In vivo effects of rosiglitazone in a human neuroblastoma xenograft
2010 I.Cellai; G.Petrangolini; M.Tortoreto; G.Pratesi; P.Luciani; C.Deledda; S.Benvenuti; C.Ricordati; S.Gelmini; E.Ceni; A.Galli; M.Balzi; P.Faraoni; M.Serio; A.Peri
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
2010 GALLI A; CENI E; MELLO T; POLVANI S; TAROCCHI M; BUCCOLIERO F; LISI F; CIONI L; OTTANELLI B; FORESTA V; MASTROBUONI G; MONETI G; PIERACCINI G; SURRENTI C; MILANI S
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice.
2011 S.Polvani; M.Calamante; V.Foresta; E.Ceni; A.Mordini; A.Quattrone; M.D'Amico; C.Luchinat; I.Bertini; A.Galli
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model
2011 T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;L. Cioni;S. Milani;A. Galli
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma
2011 M. Tarocchi;S. Polvani;T. Mello;E. Ceni;F. Buccoliero;L. Cioni;S. Milani;A. Galli
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1
2012 T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;S. Milani;A. Galli
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma
2012 M. Tarocchi;S. Polvani;A. J. Peired;T. Mello;E. Ceni;F. Buccoliero;S. Deiana;C. Parrini;G. Pieraccini;C. Luchinat;I. Bertini;S. Milani;A. Galli
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury
2012 M. Tarocchi;S. Vellei;F. Buccoliero;T. Mello;S. Polvani;E. Ceni;S. Milani;A. Galli
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma
2012 M. Tarocchi;S. Polvani;M. Calamante;T. Mello;F. Buccoliero;E. Ceni;C. Luchinat;I. Bertini;S. Milani;A. Galli
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression.
2013 S. Polvani;M. Tarocchi;S. Tempesti;T. Mello;E. Ceni;F. Buccoliero;M. D'Amico;V. Boddi;M. Farsi;S. Nesi;G. Nesi;S. Milani;A. Galli
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS
2014 Mello, T; Tarocchi, M; Perini, F; Buccoliero, F; Marroncini, G; Ceni, E; Polvani, S; Tempesti, S; Milani, S; Galli, A
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma
2014 Mirko Tarocchi;Simone Polvani;Anna Julie Peired;Giada Marroncini;Massimo Calamante;Elisabetta Ceni;Daniela Rhodes;Tommaso Mello;Giuseppe Pieraccini;Alessandro Quattrone;Claudio Luchinat;Andrea Galli
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism.
2014 Ceni E; Mello T; Galli A.
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
2015 Poli, Giada; Ceni, Elisabetta; Armignacco, Roberta; Ercolino, Tonino; Canu, Letizia; Baroni, Gianna; Nesi, Gabriella; Galli, Andrea; Mannelli, Massimo; Luconi, Michaela
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS
2015 Tarocchi, M ; Marroncini, G ; Polvani, S ; Tempesti, S ; Mello, T; Ceni, E ; Milani, S ; Peluso, M] ; Galli, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. | 2008 | Giulia Cantini; Adriana Lombardi; Elisabetta Piscitelli; Giada Poli; Elisabetta Ceni; Sara Marchiani; Tonino Ercolino; Andrea Galli; Mario Serio; Massimo Mannelli; Michaela Luconi | |
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells | 2008 | A. Lombardi; G. Cantini; E. Piscitelli; S. Gelmini; M. Francalanci; T. Mello; E. Ceni; G. Varano; G. Forti; M. Rotondi; A. Galli; M. Serio; M. Luconi | |
Alcohol induced hepatic fibrosis: role of acetaldehyde. | 2008 | Tommaso Mello; Elisabetta Ceni; Calogero Surrenti; Andrea Galli | |
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN | 2009 | M. Tarocchi;E. Ceni;T. Mello;S. Polvani;F. Buccoliero;L. Cioni;B. Ottanelli;V. Foresta;S. Milani;A. Galli | |
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. | 2010 | Cantini G; Lombardi A; Borgogni E; Francalanci M; Ceni E; Degl'Innocenti S; Gelmini S; Poli G; Galli A; Serio M; Forti G; Luconi M. | |
In vivo effects of rosiglitazone in a human neuroblastoma xenograft | 2010 | I.Cellai; G.Petrangolini; M.Tortoreto; G.Pratesi; P.Luciani; C.Deledda; S.Benvenuti; C.Ricordati; S.Gelmini; E.Ceni; A.Galli; M.Balzi; P.Faraoni; M.Serio; A.Peri | |
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. | 2010 | GALLI A; CENI E; MELLO T; POLVANI S; TAROCCHI M; BUCCOLIERO F; LISI F; CIONI L; OTTANELLI B; FORESTA V; MASTROBUONI G; MONETI G; PIERACCINI G; SURRENTI C; MILANI S | |
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. | 2011 | S.Polvani; M.Calamante; V.Foresta; E.Ceni; A.Mordini; A.Quattrone; M.D'Amico; C.Luchinat; I.Bertini; A.Galli | |
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model | 2011 | T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;L. Cioni;S. Milani;A. Galli | |
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma | 2011 | M. Tarocchi;S. Polvani;T. Mello;E. Ceni;F. Buccoliero;L. Cioni;S. Milani;A. Galli | |
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 | 2012 | T. Mello;M. Tarocchi;F. Buccoliero;E. Ceni;S. Polvani;S. Milani;A. Galli | |
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma | 2012 | M. Tarocchi;S. Polvani;A. J. Peired;T. Mello;E. Ceni;F. Buccoliero;S. Deiana;C. Parrini;G. Pieraccini;C. Luchinat;I. Bertini;S. Milani;A. Galli | |
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury | 2012 | M. Tarocchi;S. Vellei;F. Buccoliero;T. Mello;S. Polvani;E. Ceni;S. Milani;A. Galli | |
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma | 2012 | M. Tarocchi;S. Polvani;M. Calamante;T. Mello;F. Buccoliero;E. Ceni;C. Luchinat;I. Bertini;S. Milani;A. Galli | |
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. | 2013 | S. Polvani;M. Tarocchi;S. Tempesti;T. Mello;E. Ceni;F. Buccoliero;M. D'Amico;V. Boddi;M. Farsi;S. Nesi;G. Nesi;S. Milani;A. Galli | |
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS | 2014 | Mello, T; Tarocchi, M; Perini, F; Buccoliero, F; Marroncini, G; Ceni, E; Polvani, S; Tempesti, S; Milani, S; Galli, A | |
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma | 2014 | Mirko Tarocchi;Simone Polvani;Anna Julie Peired;Giada Marroncini;Massimo Calamante;Elisabetta Ceni;Daniela Rhodes;Tommaso Mello;Giuseppe Pieraccini;Alessandro Quattrone;Claudio Luchinat;Andrea Galli | |
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. | 2014 | Ceni E; Mello T; Galli A. | |
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma | 2015 | Poli, Giada; Ceni, Elisabetta; Armignacco, Roberta; Ercolino, Tonino; Canu, Letizia; Baroni, Gianna; Nesi, Gabriella; Galli, Andrea; Mannelli, Massimo; Luconi, Michaela | |
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS | 2015 | Tarocchi, M ; Marroncini, G ; Polvani, S ; Tempesti, S ; Mello, T; Ceni, E ; Milani, S ; Peluso, M] ; Galli, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile